Kaplan Benjamin
SEC insider (Form 3/4/5 filer). CIK 0001850761. CEO at Mycotopia Therapies, Inc. (TPIA). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 13, 2024. Located in MIAMI, FL.
Companies Kaplan Benjamin has filed insider reports for
- Mycotopia Therapies, Inc. (TPIA): Director, Officer, CEO
Kaplan Benjamin
CIK: 0001850761
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TPIA
Mycotopia Therapies, Inc.
DirectorOfficer